This report up-dates information on the national situation of cervical cancer screening in the
member states of the European Union. There is yet high diversity in the status of cervical …

Background: This randomised study compared the detection rate of cervical intraepithelial
neoplasia-positive (CIN2+) based on histology in women performing repeated self-sampling …

Cervical cancer is the 11th leading cause of death from cancer for females in Japan. In
2005, there were 2486 deaths from cervical cancer, accounting for 1.8% of the total number …

Background Cancer screening is a complex process encompassing risk assessment, the
initial screening examination, diagnostic evaluation, and treatment of cancer precursors or …

Background High-risk human papillomavirus (HR-HPV) is notoriously associated with tumor
progression in a broad spectrum of malignancies. Detection of HR-HPV is clinically …

Background: There is currently some uncertainty about the effectiveness of screening
outside the established core ages of 30 to 60. We audited the screening histories of cervical …

High screening participation in the population is essential for optimal prevention of cervical
cancer. Offering a high‐risk human papillomavirus (HPV) self‐test has previously been …

We conducted a randomized, controlled trial to evaluate different strategies of offering an
HPV‐self sampling program, and compared this with two control groups. All total of 35,354 …

The detection of cancer in its early latent stages can improve a patient's chances of recovery
and thereby reduce the overall burden of the disease. Cancer screening services are …

Background According to international guidelines, Human Papillomavirus (HPV) DNA tests
represent a valid alternative to Pap Test for primary cervical cancer screening, provided that …